Home Strains

Strains

For legal purposes, the majority of CBD oil products on the market today are being made from industrial hemp plants. There is a fairly significant difference (which we’ll talk about here shortly) between these plants and actual marijuana, with the latter actual being legal in all 50 U.S. states and the former (that is, marijuana) of course […]
PORTLAND, Ore. (AP) — Green Thumb Industries had a business plan, expertise and plenty of ambition to grow its marijuana business. What the Chicago-based company didn’t have was access to enough capital to make it all happen. So last month, the company with $20 million in revenue from pot shops in seven states turned its […]
The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not “generally recognized as safe and effective.” The move is “not necessary for the protection of public health,” Janet Woodcock, the director of FDA’s Center for Drug […]
But regulations around edibles currently prohibit this green beer from being sold An Alberta-based cannabis producer is hoping to grease the wheels of the liquor industry with a little marijuana oil. Element GP, based in Clearwater County, plans to provide the key ingredient for a non-alcoholic beer that is brewed from cannabis oil. The producer has joined […]
Call it the California Marijuanapocalypse of 2018. As of January 1, recreation cannabis has been legal in the state. A black market still runs underneath it all (Northern California alone supplies perhaps 75 percent of all marijuana across the United States), but cultivators and distributors are going legit, bringing themselves up to the rigorous testing […]
The National Cannabis Industry Association’s Cannabis Business Summit™ & Expo is officially the fastest-growing annual trade show in the United States, according to Trade Show Executive. The Cannabis Business Summit, NCIA’s flagship annual event, was awarded the top spot on Trade Show Executive’s annual “Fastest 50” list, honoring the 50 fastest-growing annual trade shows of the year. […]
The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment. The drug, Epidiolex, is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and […]
Regulators at the US Food and Drug Administration today granted market approval for Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. The FDA’s decision was not unexpected, as the proprietary extract formulation — developed by the British biotechnology firm GW […]